Regen BioPharma Discovers Potential New Way to Improve Outcomes from Cancer Surgery Using Combination of Cannabidiol and NR2F6 Inhibition

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today data demonstrating its unique combination of NR2F6 inhibition together with…